960化工网
Asymmetric reduction of a key intermediate of eslicarbazepine acetate using whole cell biotransformation in a biphasic medium
Manpreet Singh,Sawraj Singh,Sateesh Deshaboina,Hare Krishnen,Richard Lloyd,Karen Holt-Tiffin,Apurba Bhattacharya,Rakeshwar Bandichhor
Catalysis Science & Technology Pub Date : 02/10/2012 00:00:00 , DOI:10.1039/C2CY00537A
Abstract

A whole-cell mediated asymmetric reduction of oxcarbazepine 1 to S-licarbazepine 2, a key intermediate in the synthesis of Eslicarbazepine acetate, was achieved using the yeast strain Pichia methanolica 103660. The reduction was carried out in a biphasic system consisting of (1 : 1) de-ionized water and hexane. This organism catalyzed the reaction to yield the S-enantiomer 2 with excellent conversion (>98%) and enantiomeric excess (ee > 98%) within 24 h of incubation.

Graphical abstract: Asymmetric reduction of a key intermediate of eslicarbazepine acetate using whole cell biotransformation in a biphasic medium
平台客服
平台客服
平台在线客服